FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fiona Lalloo

Research Profile

Genes & Molecular Sequences

Physiology

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Activities & Behaviors

Family

Geographic Areas

England

Co-author Network

Publications

TOP 3
P J Barrow; K Green; J Hill; S Ingham; Fiona Lalloo; I McIntyre; C O'Hara; D G Evans
The spectrum of urological malignancy in Lynch syndrome.
Fiona Lalloo; D G Evans
Familial breast cancer.
A Moran; C O'Hara; L Shack; E Woodward; S Khan; Fiona Lalloo; E R Maher; D G R Evans
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fiona Lalloo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: P J Barrow; K Green; J Hill; S Ingham; Fiona Lalloo; I McIntyre; C O'Hara; D G Evans
The spectrum of urological malignancy in Lynch syndrome.
Familial cancer 2013;12(1):57-63.
2012: Fiona Lalloo; D G Evans
Familial breast cancer.
Clinical genetics 2012;82(2):105-14.
2012: A Moran; C O'Hara; L Shack; E Woodward; S Khan; Fiona Lalloo; E R Maher; D G R Evans
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
Familial cancer 2012;11(2):235-42.
2012: K F Newton; E K L Mallinson; J Bowen; T Clancy; James Hill; Fiona Lalloo; D G R Evans
Genotype-phenotype correlation in colorectal polyposis.
Clinical genetics 2012;81(6):521-31.
2012: Anna Wilding; Tara Clancy; Susan M Huson; Sarah Louise Ingham; Fiona Lalloo; Anthony Moran; D Gareth Evans
Life expectancy in hereditary cancer predisposing diseases: an observational study.
Journal of medical genetics 2012;49(4):264-9.
2011: D G R Evans; Anthony Howell; J L Jones; Fiona Lalloo; D Ward; Diana Eccles
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer.
Journal of medical genetics 2011;48(8):520-2.
2010: E K L Mallinson; K F Newton; J Bowen; Fiona Lalloo; T Clancy; J Hill; D G R Evans
The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
Gut 2010;59(10):1378-82.
2010: D G R Evans; I Susnerwala; J Dawson; Emma R Woodward; Eamonn R Maher; Fiona Lalloo
Risk of breast cancer in male BRCA2 carriers.
Journal of medical genetics 2010;47(10):710-1.
2010: J Bergqvist; A Latif; S A Roberts; K D Hadfield; Fiona Lalloo; A Howell; D G Evans; W G Newman
RASSF1A polymorphism in familial breast cancer.
Familial cancer 2010;9(3):263-5.
2010: D Gareth Evans; Munaza Ahmed; Stuart Bayliss; E Howard; Fiona Lalloo; A Wallace
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries.
Journal of medical genetics 2010;47(8):561-6.
2010: D G R Evans; E Howard; C Giblin; T Clancy; H Spencer; Susan M Huson; Fiona Lalloo
Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
American journal of medical genetics. Part A 2010;152A(2):327-32.
2010: Christopher J Ricketts; Julia R Forman; Eleanor Rattenberry; Nicola Bradshaw; Fiona Lalloo; Louise Izatt; TR Cole; Ruth Armstrong; V K Ajith Kumar; Patrick J Morrison; Brew Atkinson; Fiona Douglas; Steve G Ball; Jackie Cook; Umasuthan Srirangalingam; Pip Killick; Gail Kirby; Simon Aylwin; Emma R Woodward; D Gareth R Evans; Shirley V Hodgson; Vicky Murday; Shern L Chew; John M Connell; Tom L Blundell; Fiona Macdonald; Eamonn R Maher
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
Human mutation 2010;31(1):41-51.
2009: A Osorio; R L Milne; G Pita; P Peterlongo; T Heikkinen; J Simard; G Chenevix-Trench; A B Spurdle; J Beesley; X Chen; S Healey; S L Neuhausen; Y C Ding; F J Couch; X Wang; N Lindor; S Manoukian; M Barile; A Viel; L Tizzoni; C I Szabo; L Foretova; M Zikan; K Claes; M H Greene; P Mai; G Rennert; F Lejbkowicz; O Barnett-Griness; I L Andrulis; H Ozcelik; N Weerasooriya; A-M Gerdes; M Thomassen; D G Cruger; M A Caligo; Eitan Friedman; B Kaufman; Y Laitman; S Cohen; T Kontorovich; R Gershoni-Baruch; E Dagan; H Jernström; M S Askmalm; B Arver; B Malmer; S M Domchek; K L Nathanson; J Brunet; T Ramón Y Cajal; D Yannoukakos; U Hamann; F B L Hogervorst; S Verhoef; E B Gómez García; Juul Wijnen; A van den Ouweland; D F Easton; S Peock; M Cook; C T Oliver; D Frost; C Luccarini; D G Evans; Fiona Lalloo; R Eeles; G Pichert; J Cook; S Hodgson; P J Morrison; F Douglas; A K Godwin; O M Sinilnikova; L Barjhoux; D Stoppa-Lyonnet; V Moncoutier; S Giraud; C Cassini; L Olivier-Faivre; F Révillion; J-P Peyrat; D Muller; J-P Fricker; H T Lynch; E M John; S Buys; M Daly; J L Hopper; M B Terry; A Miron; Y Yassin; D Goldgar; C F Singer; D Gschwantler-Kaulich; G Pfeiler; A-C Spiess; Thomas V O Hansen; O T Johannsson; Tomas Kirchhoff; Kenneth Offit; K Kosarin; M Piedmonte; Gustavo Rodriguez; K Wakeley; J F Boggess; J Basil; P E Schwartz; S V Blank; A E Toland; M Montagna; C Casella; E N Imyanitov; A Allavena; R K Schmutzler; B Versmold; C Engel; A Meindl; N Ditsch; N Arnold; D Niederacher; H Deissler; B Fiebig; R Varon-Mateeva; D Schaefer; U G Froster; T Caldes; M de la Hoya; L McGuffog; A C Antoniou; H Nevanlinna; P Radice; J Benítez
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
British journal of cancer 2009;101(12):2048-54.
2009: Antonis C Antoniou; Olga M Sinilnikova; Lesley McGuffog; Sue Healey; Heli Nevanlinna; Tuomas Heikkinen; Jacques Simard; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Susan L Neuhausen; Yuan C Ding; Fergus J Couch; Xianshu Wang; Zachary Fredericksen; Paolo Peterlongo; Bernard Peissel; Bernardo Bonanni; Alessandra Viel; Loris Bernard; Paolo Radice; Csilla I Szabo; Lenka Foretova; Michal Zikan; Kathleen Claes; Mark H Greene; Phuong L Mai; Gad Rennert; Flavio Lejbkowicz; Irene L Andrulis; Hilmi Ozcelik; Gord Glendon; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Maria A Caligo; Yael Laitman; Tair Kontorovich; Shimrit Cohen; Bella Kaufman; Efrat Dagan; Ruth Gershoni Baruch; Eitan Friedman; Katja Harbst; Gisela Barbany-Bustinza; Johanna Rantala; Hans Ehrencrona; Per Karlsson; Susan M Domchek; Katherine L Nathanson; Ana Osorio; Ignacio Blanco; Adriana Lasa; Javier Benítez; Ute Hamann; Frans B L Hogervorst; Matti A Rookus; J Margriet Collee; Peter Devilee; Marjolijn J Ligtenberg; Rob B van der Luijt; Cora M Aalfs; Quinten Waisfisz; Juul Wijnen; Cornelis E P van Roozendaal; Susan Peock; Margaret Cook; Debra Frost; Clare Oliver; Radka Platte; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Rosemarie Davidson; Carol Chu; Diana Eccles; Trevor Cole; Shirley Hodgson; Andrew K Godwin; Dominique Stoppa-Lyonnet; Bruno Buecher; Mélanie Léoné; Brigitte Bressac-de Paillerets; Audrey Remenieras; Olivier Caron; Gilbert M Lenoir; Nicolas Sevenet; Michel Longy; Sandra Fert Ferrer; Fabienne Prieur; David Goldgar; Alexander Miron; Esther M John; Saundra S Buys; Mary B Daly; John L Hopper; Mary Beth Terry; Yosuf Yassin; Christian Singer; Daphne Gschwantler-Kaulich; Christine Staudigl; Thomas v O Hansen; Rosa Bjork Barkardottir; Tomas Kirchhoff; Prodipto Pal; Kristi Kosarin; Kenneth Offit; Marion Piedmonte; Gustavo Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Peter E Schwartz; Stephanie V Blank; Amanda E Toland; Marco Montagna; Cinzia Casella; Evgeny N Imyanitov; Anna Allavena; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Dieter Niederacher; Helmut Deissler; Britta Fiebig; Christian Suttner; Ines Schönbuchner; Dorothea Gadzicki; Trinidad Caldes; Miguel de la Hoya; Karen A Pooley; Douglas F Easton; Georgia Chenevix-Trench
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human molecular genetics 2009;18(22):4442-56.
2009: O M Sinilnikova; A C Antoniou; J Simard; S Healey; M Léoné; D Sinnett; A B Spurdle; J Beesley; X Chen; M H Greene; J T Loud; F Lejbkowicz; G Rennert; S Dishon; I L Andrulis; S M Domchek; K L Nathanson; S Manoukian; P Radice; I Konstantopoulou; I Blanco; Alice Laborde; M Durán; A Osorio; J Benitez; U Hamann; F B L Hogervorst; T A M van Os; H J P Gille; S Peock; M Cook; C Luccarini; D G Evans; Fiona Lalloo; R Eeles; G Pichert; R Davidson; T Cole; J Cook; J Paterson; C Brewer; D J Hughes; I Coupier; S Giraud; F Coulet; C Colas; F Soubrier; E Rouleau; I Bièche; R Lidereau; L Demange; C Nogues; H T Lynch; R K Schmutzler; B Versmold; C Engel; A Meindl; N Arnold; C Sutter; H Deissler; D Schaefer; U G Froster; K Aittomäki; H Nevanlinna; L McGuffog; D F Easton; G Chenevix-Trench; D Stoppa-Lyonnet
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
British journal of cancer 2009;101(8):1456-60.
2009: Sharon E Johnatty; Fergus J. Couch; Zachary Fredericksen; Robert Tarrell; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Daphne Gschwantler-Kaulich; Christian F Singer; Christine Fuerhauser; Anneliese Fink-Retter; Susan M Domchek; Katherine L Nathanson; Vernon S Pankratz; Noralane Lindor; Andrew K Godwin; Maria A Caligo; John Hopper; Melissa C Southey; Graham G Giles; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Tuomas Heikkinen; Kirsimari Aaltonen; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Per Hall; Kamila Czene; Jianjun Liu; Susan Peock; Margaret Cook; Radka Platte; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Gabriella Pichert; Diana Eccles; Rosemarie Davidson; Trevor Cole; Jackie Cook; Fiona Douglas; Carol Chu; Shirley Hodgson; Joan Paterson; Frans B L Hogervorst; Matti A Rookus; Caroline Seynaeve; Juul Wijnen; Maaike Vreeswijk; Marjolijn Ligtenberg; Rob B van der Luijt; Theo A M van Os; Hans J P Gille; Marinus J Blok; Claudine Issacs; Manjeet K Humphreys; Lesley McGuffog; Sue Healey; Olga Sinilnikova; Antonis C Antoniou; Douglas F Easton; Georgia Chenevix-Trench
No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
Breast cancer research and treatment 2009;117(2):371-9.
2009: D G R Evans; A D Baildam; E Anderson; A Brain; A Shenton; H F A Vasen; D Eccles; A Lucassen; G Pichert; H Hamed; P Moller; L Maehle; P J Morrison; D Stoppat-Lyonnet; H Gregory; E Smyth; D Niederacher; C Nestle-Krämling; J Campbell; P Hopwood; Fiona Lalloo; A Howell
Risk reducing mastectomy: outcomes in 10 European centres.
Journal of medical genetics 2009;46(4):254-8.
2008: Louise M Byrd; Andrew Shenton; Eamonn R Maher; Emma Woodward; Rachel Belk; Caron Lim; Fiona Lalloo; Anthony Howell; Gordon C Jayson; Gareth D Evans
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(6):1535-42.
2008: A C Antoniou; A P Cunningham; J Peto; D G Evans; Fiona Lalloo; steven narod; H A Risch; J E Eyfjord; J L Hopper; M C Southey; H Olsson; O Johannsson; A Borg; B Pasini; B Passini; P Radice; S Manoukian; D M Eccles; Nelson Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; L Tryggvadottir; K Syrjakoski; Olli Kallioniemi; H Eerola; H Nevanlinna; P D P Pharoah; D F Easton
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
British journal of cancer 2008;98(8):1457-66.
2008: D G R Evans; Mike Bulman; Karen Young; Emma Howard; Stuart Bayliss; Andrew Wallace; Fiona Lalloo
BRCA1/2 mutation analysis in male breast cancer families from North West England.
Familial cancer 2008;7(2):113-7.
2007: Asif Ali; Paul T Christie; Irina V Grigorieva; Brian Harding; Hilde Van Esch; S Faisal Ahmed; Maria Bitner-Glindzicz; Eberhard Blind; Catherine Bloch; Patricia Christin; Peter Clayton; Jozef Gecz; Brigitte Gilbert-Dussardier; Encarna Guillen-Navarro; Anna Hackett; Isil Halac; Geoffrey N Hendy; Fiona Lalloo; Christoph J Mache; Zulf Mughal; Albert C M Ong; Choni Rinat; Nicholas Shaw; Sarah F Smithson; John Tolmie; Jacques Weill; M Andrew Nesbit; Rajesh V Thakker
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.
Human molecular genetics 2007;16(3):265-75.
2005: Sunil R Lakhani; Jorge S Reis-Filho; Laura Fulford; Frederique Penault-Llorca; Marc van der Vijver; Suzanne Parry; Timothy Bishop; Javier Benitez; Carmen Rivas; Yves-Jean Bignon; Jenny Chang-Claude; Ute Hamann; Cees J Cornelisse; Peter Devilee; Matthias W Beckmann; Carolin Nestle-Krämling; Peter A Daly; Neva Haites; Jenny Varley; Fiona Lalloo; Gareth Evans; Christine Maugard; Hanne Meijers-Heijboer; Jan G M Klijn; Edith Olah; barry gusterson; Silvana Pilotti; Paolo Radice; Siegfried Scherneck; Hagay Sobol; Jocelyne Jacquemier; Teresa Wagner; Julian Peto; Michael R Stratton; Lesley McGuffog; Douglas F Easton
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5175-80.
2005: A C Antoniou; P D P Pharoah; steven narod; H A Risch; J E Eyfjord; J L Hopper; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; Olli Kallioniemi; D Thompson; C Evans; J Peto; Fiona Lalloo; D G Evans; D F Easton
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
Journal of medical genetics 2005;42(7):602-3.
2005: D G R Evans; Fiona Lalloo; A Wallace; N Rahman
Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
Journal of medical genetics 2005;42(7):e39.
2004: Tasoula Tsilchorozidou; F H Menko; Fiona Lalloo; A Kidd; R De Silva; H Thomas; P Smith; A Malcolmson; J Dore; K Madan; A Brown; John G Yovos; M Tsaligopoulos; N Vogiatzis; Michael E Baser; Andrew J Wallace; D G R Evans
Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.
Journal of medical genetics 2004;41(7):529-34.
2003: Dewi Astuti; Niki Hart-Holden; Farida Latif; Fiona Lalloo; Graeme C M Black; Caron Lim; Anthony Moran; Ashley B Grossman; Shirley V Hodgson; Anthony Freemont; Richard Ramsden; Charis Eng; D G R Evans; Eamonn R Maher
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Clinical endocrinology 2003;59(6):728-33.
2003: A Antoniou; P D P Pharoah; steven narod; H A Risch; J E Eyfjord; J L Hopper; Niklas Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; Olli Kallioniemi; D Thompson; C Evans; J Peto; Fiona Lalloo; D G Evans; D F Easton
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
American journal of human genetics 2003;72(5):1117-30.
2002: D G R Evans; Jillian M Birch; M Thorneycroft; Gail McGown; Fiona Lalloo; Jennifer M Varley
Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
Journal of medical genetics 2002;39(12):941-4.
2000: C J Heaven; Fiona Lalloo; E Mchale
Keratoconus associated with chromosome 13 ring abnormality.
The British journal of ophthalmology 2000;84(9):1079.
1999: Fiona Lalloo; D G Evans
The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.
Breast cancer research : BCR 1999;1(1):48-51.
1991: John Burn; P Chapman; J D A Delhanty; C Wood; Fiona Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.
Journal of medical genetics 1991;28(5):289-96.